Medical Weight Loss for Pittsburgh, Pennsylvania Residents
Pittsburgh, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Pittsburgh through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Pittsburgh Residents Choose New Hope Weight Loss
Pittsburgh patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Pennsylvania and beyond since 2020.
Pittsburgh is served through telehealth from our Costa Mesa, California clinic. The consultation, prescription, and follow-ups all happen by secure video, no travel to California required.
In Pittsburgh, Pennsylvania, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout Downtown, the Strip District, Shadyside, Squirrel Hill, the South Side, and the greater Pittsburgh area. There is no distance surcharge for Pittsburgh patients, and HSA, FSA, Klarna, and Affirm are all accepted.
For Pittsburgh residents, being seen by video means starting this week instead of waiting for an in-person appointment. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you before you begin.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Pittsburgh patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Pittsburgh
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Pittsburgh address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Pittsburgh
How do I get treatment from Pittsburgh?
As a Pittsburgh, Pennsylvania patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Pittsburgh?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Pittsburgh in cold-pack packaging, no lines and no drive.
How much does it cost for Pittsburgh patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Pittsburgh do you serve?
We serve patients from across Pittsburgh by telehealth, including Downtown, the Strip District, Shadyside, Squirrel Hill, the South Side, and the greater Pittsburgh area.
How does the first telehealth appointment work for Pittsburgh patients?
Start with the 2-minute quiz or the medical intake form. Dr. Sharma reviews your history by secure video, and if you are a candidate and telehealth-eligible, your prescription goes to the 503(a) pharmacy for shipping to Pittsburgh.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Pittsburgh, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.